Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CBLB | Q13191 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GRK2 | P25098 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6117144 | 0.92 | BBOX1 (0.36) | BBOX1POLB | |
| SCHEMBL2110268 | 0.90 | BBOX1 (0.39) | BBOX1KMT2AATM | |
| SCHEMBL969702 | 0.89 | BBOX1 (0.37) | BBOX1 | |
| SCHEMBL6117441 | 0.88 | TGFBR1 (0.30) | — | |
| SCHEMBL153023 | 0.87 | POLB (0.37) | BBOX1POLB | |
| SCHEMBL3764634 | 0.87 | BBOX1 (0.43) | BBOX1KMT2AATMCBLBMEN1 | |
| Hydrochloric Acid SCHEMBL6117375 | 0.85 | BBOX1 (0.42) | BBOX1KMT2AATMCBLBMEN1 | |
| Fluoride Ion SCHEMBL8583069 | 0.85 | BBOX1 (0.42) | BBOX1KMT2AATMCBLBMEN1 | |
| SCHEMBL6118217 | 0.83 | POLB (0.36) | BBOX1POLB | |
| SCHEMBL4671317 | 0.81 | POLB (0.38) | BBOX1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3016717-A1 | AMPHOTERIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS | The Procter & Gamble Company (US) | 2016-05-11 | — | — | EP | disclosed |
| US-20150011450-A1 | Amphoteric Ter-Polymers For Use in Personal Care Compositions | THE PROCTER & GAMBLE COMPANY | 2015-01-08 | — | — | US | disclosed |
| WO-2015003035-A1 | AMPHOTERIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011450-A1 | Amphoteric Ter-Polymers For Use in Personal Care Compositions | C3AR1, H1-10, HRH3 | BBOX1 3960/4885KMT2A 2178/4885ATM 2829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.